As coronavirus cases continue to rise in India, the Central Drugs Standard Control Organisation has approved five drugs to treat COVID-19 patients
Out of these, two are antiviral drugs - Remdesivir and Favipiravir, and the remaining three – Dexamethasone, Tocilizumab and Itolizumab – are for easing symptoms.
Since trials to determine the drugs’ safety and efficacy are either underway or have ended with negative results, experts have questioned their approvals.
Almost all the drugs are highly-priced too.
Here's a list of the drugs you may be prescribed and the controversies they are mired in.
Stock footage from videvo downloaded from https://www.videvo.net/
Like our work? Click here to support The Wire: https://thewire.in/support
The founding premise of The Wire is this: if good journalism is to survive and thrive, it can only do so by being both editorially and financially independent. This means relying principally on contributions from readers and concerned citizens who have no interest other than to sustain a space for quality journalism. As a publication, The Wire will be firmly committed to the public interest and democratic values.
We publish in four different languages!
For English, visit www.thewire.in
for Hindi: http://thewirehindi.com/
for Urdu: http://thewireurdu.com
for Marathi: https://marathi.thewire.in
If you are a young writer or a creator, you can submit articles, essays, photos, poetry – anything that’s straight out of your imagination – to LiveWire, The Wire’s portal for the young, by the young. https://livewire.thewire.in/
You can also follow The Wire’s social media platforms and engage with us.
Facebook
https://www.facebook.com/TheWire/
https://www.facebook.com/TheWireHindi/
https://www.facebook.com/TheWireUrdu/
https://www.facebook.com/TheWireMarathi/
Twitter
https://twitter.com/thewire_in
https://twitter.com/thewirehindi
https://twitter.com/TheWireUrdu
https://twitter.com/TheWireMarathi
https://twitter.com/livewire
Instagram
https://www.instagram.com/thewirein/
https://www.instagram.com/livewirein/
Don’t forget to hit the subscribe button to never miss a video from The Wire!